ChemotherapyInvestigationalSecond-line
MM-398
Generic name: nolotinib
How it works
MM-398 is a topoisomerase inhibitor that prevents cancer cells from growing and dividing.
Cancer types
Pancreatic Cancer— All patients
Efficacy
MM-398 in combination with gemcitabine has been shown to improve overall survival in patients with metastatic pancreatic cancer, compared to gemcitabine alone, in clinical trials.
Side effects
Moderate
Side effects can be significant and may require dose adjustments or supportive medication, but the treatment is usually continued.
This information is provided for general education only and is not medical advice. Always consult a qualified healthcare professional before making treatment decisions.